Tarsus Pharmaceuticals, Inc. TARS 深 滬
已收盤 02-06 16:00:00 美东时间
64.62
+2.630
+4.24%
華盛通- 最 高64.79
- 今 開62.55
- 成交量 79.96万股
- 最 低 62.37
- 昨 收 61.99
- 總市值 27.43亿
- 52周最高 85.25
- 市盈率 靜 --
- 換手率 1.88%
- 52周最低 38.51
- 委 比 58.09%
- 總股本 4244.91万
- 歷史最高 85.25
- 量 比 1.43
- 振 幅 3.90%
- 歷史最低 10.80
- 每 手 1
- 風險率 13.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Barclays Initiates Coverage On Tarsus Pharmaceuticals with Overweight Rating, Announces Price Target of $100
Barclays analyst Glen Santangelo initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Overweight rating and announces Price Target of $100.
2025-12-10 00:19
美股大行评级 | 最高352美元！14家机构连夜上调英伟达目标价；劳氏、塔吉特、Wix.com等遭多家机构下调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从22美元升至23美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从24美元升至26美元
2025-11-21 15:50
Mizuho Initiates Coverage On Tarsus Pharmaceuticals with Outperform Rating, Announces Price Target of $100
Mizuho analyst Graig Suvannavejh initiates coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform rating and announces Price Target of $100.
2025-11-21 00:10
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
2025-11-06 09:55
Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $87
Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $84 to $87.
2025-11-05 23:04
Tarsus Pharmaceuticals shares are trading lower. The company reported Q3 financial results.
Tarsus Pharmaceuticals shares are trading lower. The company reported Q3 financ...
2025-11-05 06:10
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
2025-10-21 18:13
HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $88
HC Wainwright & Co. analyst Matthew Caufield maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $72 to $88.
2025-10-20 18:40
Top 2 Health Care Stocks That May Fall Off A Cliff In August
As of Aug. 20, 2025, two stocks in the health care sector could be flashing a r...
2025-08-20 20:46
